MO HB932

Requires health insurers and utilization review organizations to base step therapy protocols on clinical practice guidelines independently developed by professional medical societies with relevant expertise

Mandates insurers provide patients and prescribers a clear process to request step therapy exceptions, which must be granted when required drugs are contraindicated, expected to be ineffective, previously tried without success, or not in the patient's best interest

Requires annual certification to the Missouri Department of Insurance that step therapy criteria meet clinical guideline standards, and mandates submission of clinical review criteria for approval prior to implementation

Obligates insurers to report annually on step therapy exception requests, including total requests received and approval/denial rates

Applies to health insurance plans delivered, issued, or renewed on or after January 1, 2016